Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE

D'Agostino MA, Schett G, Lopez-Rdz A, Senolt L, Fazekas K, Burgos-Vargas R, Maldonado-Cocco J, Naredo E, Carron P, Duggan AM, Goyanka P, Boers M, Gaillez C (2021)

Publication Type: Journal article

Publication year: 2021

Journal

Rheumatology Oxford University Press

DOI: 10.1093/rheumatology/keab628

Abstract

Objectives. To investigate the dynamics of response of synovitis to IL-17A inhibition with secukinumab in patients with active PsA using Power Doppler ultrasound.

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore

Italy (IT) Univerzita Karlova v Praze / Charles University in Prague

Czech Republic (CZ) Miskolc Semmelweis Hospital / Semmelweis Tagkórház

Hungary (HU) Hospital General de México

Mexico (MX) Universidad de Buenos Aires (UBA) / University of Buenos Aires

Argentina (AR) Hospital Universitario Fundación Jiménez Díaz

Spain (ES) University Hospital Ghent

Belgium (BE) Novartis Ireland Limited

Ireland (IE) Novartis AG

Switzerland (CH) Vrije Universiteit Amsterdam (VU) / University Amsterdam

Netherlands (NL)

How to cite

APA:

D'Agostino, M.A., Schett, G., Lopez-Rdz, A., Senolt, L., Fazekas, K., Burgos-Vargas, R.,... Gaillez, C. (2021). Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE. Rheumatology. https://doi.org/10.1093/rheumatology/keab628

MLA:

D'Agostino, Maria Antonietta, et al. "Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE." Rheumatology (2021).

BibTeX: Download